We hereby inform that, meeting of Board of Directors of the company was held today viz Tuesday, 2nd September 2025 at registered office at 5:00 P.M. and concluded at 8:00 P.M.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Kabra Drugs Ltd met on 2nd September 2025 and approved several items. The Director's Report and Corporate Governance Report for FY 2024-25 were approved. The Register of Members will be closed from 24th to 30th September 2025, with a cut-off date of 23rd September 2025 for the 36th Annual General Meeting (AGM) scheduled on 30th September 2025 at Ginger Hotel, Indore. E-voting will run from 27th to 29th September 2025. The Board also approved the appointment of M/s Karthik L & Associates as Internal Auditors for FY 2025-26 and Mr. Tanuj Jain Susilkumar as Secretarial Auditor for a five-year term (FY 2025-26 to FY 2029-30). Additionally, the Board decided to acquire new property for office purposes and approved remuneration for Mr. Kuniamuthur Nanjappan Anand.
This is a routine post-AGM preparation filing with no major surprises. The property acquisition decision could be a modest positive signal for operational expansion, while auditor appointments are standard governance updates with no material impact expected on the stock price.